Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital

Medical Mycology

Volumn 46, Issue 6, 2008, Pages 581-588

  Girao, E ^a   Levin, A S ^a   Basso, M ^a   Gobara, S ^a   Gomes, L B ^a   Medeiros, E A S ^a   Costa, S F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Candidemia; Fluconazole; Intensive care unit

Indexed keywords

CASPOFUNGIN; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; BURN; CANDIDA ALBICANS; CANDIDEMIA; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FUNGUS ISOLATION; GASTROINTESTINAL DISEASE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; ORGAN TRANSPLANTATION; PROGNOSIS; SCHOOL CHILD; SEPSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BRAZIL; CANDIDIASIS; CHILD; CROSS INFECTION; ECHINOCANDINS; FEMALE; FLUCONAZOLE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS;

EID: 51649119871     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802004996     Document Type: Article

References (37)

1. Edmond, MB, Wisplinghoff, H. Bischoff, T. et al. (2004) Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis, 39, pp. 309-318.
2. Morgan, J., Meltzer, MI Plikaytis, BD et al. (2005) Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol, 6, pp. 540-547.
3. Davis, SL, Vazquez, JA and McKinnon, PS. (2007) Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother, 41, pp. 568-573.
4. Bassetti, M., Trecarichi, EM Righi, E. et al. (2007) Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis, 58, pp. 325-331.
5. Jarvis, WR. (1995) Epidemiology of nosocomial fungal infections, with emphasis on candida species. Clin Infect Dis, 20, pp. 1526-1530.
6. Voss, A., Kluytmans, JAJW Koeleman, JGM et al. (1996) Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis, 15, pp. 990-912.
7. Weinstein, MP, Towns, ML and Quartey, SM. (1997) The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis, 24, pp. 584-602.
8. Amrutkar, PP, Rege, MD Chen, H. et al. (2006) Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection, 34, pp. 322-327.
9. Gardner, JS, Jarvis, WR and Emori, TG. (1988) CDC definitions for nosocomial infections. Am J Infect Control, 16, pp. 128-140.
10. Polk, RE, Fox, C., Mahoney, A., Letcavage, J. and MacDougall, C. (2007) Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis, 44, pp. 664-670.
11. Dean, AD, Dean, JA, Burton, JH and Dicker, RC (1998) Epi Info, version 6.04: A word processing, database and statistics program for epidemiology on microcomputers. CDC, Atlanta, GA
12. Edwards, JR, Peterson, KD Andrus, ML et al. (2007) NHSN Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control, 5, pp. 290-301.
13. Ramirez Barba, EJ, Rosenthal, VD Higuera, F. et al. (2006) Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control, 4, pp. 244-247.
14. Moreno, CA, Rosenthal, VD Olarte, N. et al. (2006) Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: Findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol, 4, pp. 349-356.
15. Rosenthal, VD, Maki, DG Salomao, R. et al. (2006) International Nosocomial Infection Control Consortium. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med, 8, pp. 582-591.
16. Marchetti, O., Bille, J. Fluckiger, U. et al. (2004) Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis, 38, pp. 311-325.
17. Al-Tawfiq, JA. (2007) Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004. Int J Infect Dis, 11, pp. 239-244.
18. Colombo, AL, Nucci, M. Park, BJ et al. (2006) Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol, 8, pp. 2816-2823.
19. Colombo, AL, Guimaraes, T. Silva, LR et al. (2007) Prospective observational study of candidemia in Sao Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol, 5, pp. 570-574.
20. White, MH. (1997) The contribution of fluconazole to the changing epidemiology of invasive candidal infections (editorial). Clin Infect Dis, 24, pp. 1129-1130.
21. Chai, YA, Wang, Y. Khoo, AL et al. (2007) Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital. Med Mycol, 5, pp. 435-439.
22. Lin, MY, Carmeli, Y. Zumsteg, J. et al. (2005) Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: A case-case-control study. Antimicrob Agents Chemother, 11, pp. 4555-4560.
23. Presterl, E., Daxbock, F., Graninger, W. and Willinger, B. (2007) Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect, 13, pp. 1072-1076.
24. Sendid, B., Cotteau, A. Francois, N. et al. (2006) Candidaemia and antifungal therapy in a French University Hospital: Rough trends over a decade and possible links. BMC Infect Dis, 6, p. 80.
25. Bassetti, M., Righi, E. Costa, A. et al. (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis, 6, p. 21.2.
26. Bedini, A., Venturelli, C. Mussini, C. et al. (2006) Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect, 12, pp. 75-80.
27. World Health Organization (2004) Collaborating Center for Drug Statistics Methodology. ATC Index with DDDs, Oslo, Norway
28. Rex, JH, Walsh, TJ Sobel, JD et al. (2000) Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis, 30, pp. 662-678.
29. Vardakas, KZ, Samonis, G., Michalopoulos, A., Soteriades, ES and Falagas, ME. (2006) Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials. Crit Care Med, 4, pp. 1216-1224.
30. Shorr, AF, Chung, K., Jackson, WL, Waterman, PE and Kollef, MH. (2005) Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis. Crit Care Med., 9, pp. 1928-1935.
31. Forrest, GN, Weekes, E. and Johnson, JK. (2007) Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect, 12
32. Brito, LR, Guimaraes, T. Nucci, M. et al. (2006) Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol, 3, pp. 261-266.
33. Safdar, A., van Rhee, F., Henslee-Downey, JP, Singhal, S. and Mehta, J. (2001) Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: No adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant, 28, pp. 873-878.
34. Crabtree, TD, Pelletier, SJ, Gleason, TG, Pruett, TL and Sawyer, RG. (1999) Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA, 22, pp. 2143-2148.
35. Alonso-Valle, H., Acha, O. Garcia-Palomo, JD et al. (2003) Candidemia in a tertiary care hospital: Epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis, 4, pp. 254-257.
36. Charles, PE, Doise, JM Quenot, JP et al. (2003) Candidemia in critically ill patients: Difference of outcome between medical and surgical patients. Intensive Care Med, 12, pp. 2162-2169.
37. Almirante, B., Rodriguez, D. Cuenca-Estrella, M. et al. (2006) Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol, 5, pp. 1681-1685.